Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for research institutions and clinical trial organizations that are seeking to change their recipient status under an existing NIH Type 7 Parent Clinical Trial grant. Eligible applicants typically include NIH-recognized research institutions, academic medical centers, hospitals, and research-focused nonprofits that hold active NIH grants and wish to transfer the grant to a different organizational entity. The grant supports the administrative and technical process of transitioning clinical trial operations to a new recipient organization while maintaining compliance with NIH regulations and the ongoing clinical trial protocol. Geographic scope includes all U.S. institutions and eligible foreign organizations with appropriate NIH certification.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The National Institutes of Health (NIH) hereby notifies recipient organizations holding specific types of NIH grants, listed within the Activity Code section above, that applications for change of recipient organization may be submitted to this NOFO. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award.
Although requests for change of recipient organization may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- NIH Form SF-424 (R&R) Application for Federal Assistance
- Project Narrative describing the reasons for organizational change and transition plan
- Budget narrative and justification for transition costs
- Institutional certifications and compliance documentation from both current and new recipient organizations
- Curriculum vitae or biosketches of key research personnel at the new organization
- Evidence of institutional support and commitment from the new recipient organization's leadership
- Documentation of IRB approval and regulatory clearances
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.213 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$22,367,527
-
$21,646,919
-
$19,236,131
-
$17,730,528
-
$15,036,701
-
$14,473,882
-
$12,748,932
-
$11,956,053
-
$11,225,697
-
$10,919,780
Top States by Funding
- CA 13 awards $83.5M
- MA 13 awards $80.2M
- WA 8 awards $69.9M
- NC 7 awards $53.8M
- NY 6 awards $40.0M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.213). How funding has trended year over year.
| 2024 | $240,178,154 | |
| 2025 | $232,899,116 | |
| 2026 est. | $2,655,626 |
FAQ
Who is eligible to apply for this grant?
Organizations that currently hold an active NIH Type 7 Parent Clinical Trial grant and seek to change their recipient organization status. This typically includes research institutions, academic medical centers, hospitals, and research nonprofits that are NIH-recognized entities.
What is the deadline for applying?
The fixed deadline is July 12, 2027. Applications open on July 11, 2024, so applicants should plan to submit well before the deadline.
What activities does this grant support?
This grant supports the administrative transfer and transition of clinical trial operations from one recipient organization to another, including protocol maintenance, regulatory compliance, and continuation of ongoing clinical trial activities.
How competitive is this grant?
This is typically less competitive than traditional R01 or R21 research grants, as it addresses a specific administrative need for organizations with active NIH clinical trial funding.
What is the typical funding range?
This is primarily an administrative transition mechanism rather than a traditional funding grant. Funding amounts depend on the scope and complexity of the clinical trial being transferred.
💡 Tips for applicants
- Begin the application process early by coordinating with your NIH program officer, who can provide guidance on the specific requirements for your Type 7 Parent Clinical Trial transfer.
- Clearly document the justification for the organizational change, including why the new recipient organization is better positioned to manage the clinical trial.
- Provide detailed organizational capacity documentation for the new recipient organization, including research infrastructure, personnel qualifications, and regulatory compliance history.
- Ensure all regulatory documentation is in order from both the current and new recipient organizations, including institutional certifications and compliance records.
- Include a comprehensive transition plan that minimizes disruption to ongoing clinical trial activities and demonstrates continuity of research operations.
⚠️ Common mistakes
Applications frequently fail due to incomplete transfer documentation or insufficient justification for the organizational change. Another common issue is inadequate description of the new recipient organization's capacity to manage the clinical trial, including regulatory compliance and personnel qualifications. Poor communication or coordination with the NIH program officer early in the process often results in missed requirements or procedural delays.
Similar grants
- OPEN Successor-in-Interest (Type 6 Parent Clinical Trial Optional) — National Institutes of Health
- CLOSED Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) — National Institutes of Health
- CLOSED NIH Research Program Projects (Parent P01 Clinical Trial Optional) — National Institutes of Health
- OPEN Predoctoral to Postdoctoral Transition Award (Parent F99/K00 – Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) — National Institutes of Health